Successful treatment of supraventricular tachycardia exhibiting hydrops fetalis with flecainide acetate. A case report.

Abstract

BACKGROUND:

The efficacy of flecainide acetate for the treatment of fetal supraventricular tachycardia with hydrops fetalis and changes in venous blood flow patterns in the fetus during treatment are reported.

CASE:

Oral flecainide administration was started at 30 weeks of gestation. Cardioversion was achieved 6 days after treatment. Sustained abnormal venous Doppler indices were shown and complete normalization of venous returns was observed 6 days after cardioversion. A vigorous male baby was born, and he is now 1 year of age and in good condition with no medication.

CONCLUSION:

Reversible cardiac dysfunction was observed even after cardioversion in the fetus with supraventricular tachycardia, which could be assessed precisely by venous Doppler analysis.

• Authors: Masahiko Nakata, Kikue Anno, Lena Tashima Matsumori, Motoki Fujiwara, Masahiro Sumie, Masakatsu Sase, Hiroshi Kato
• Journal: Fetal diagnosis and therapy (Fetal Diagn Ther) 2003 Mar-Apr Vol. 18 Issue 2 Pg. 83-6 ISSN: 1015-3837 [Print] Switzerland
• PMID: 12576741 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright 2003 S. Karger AG, Basel

Chemical References

• Flecainide

Topics

• Adult
• Female
• Flecainide (therapeutic use)
• Humans
• Hydrops Fetalis (complications, diagnostic imaging, drug therapy)
• Pregnancy
• Tachycardia, Supraventricular (complications, diagnostic imaging, drug therapy)
• Ultrasonography